Bangladesh
· Delayed Price · Currency is BDT JMISMDL Statistics
Total Valuation
JMI Syringes & Medical Devices has a market cap or net worth of BDT 4.72 billion. The enterprise value is 4.75 billion.
| Market Cap | 4.72B |
| Enterprise Value | 4.75B |
Important Dates
The next estimated earnings date is Thursday, October 24, 2024.
| Earnings Date | Oct 24, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
JMI Syringes & Medical Devices has 30.06 million shares outstanding.
| Shares Outstanding | 30.06M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +5.59% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.75 |
| PB Ratio | 1.83 |
| P/FCF Ratio | 24.87 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 33.30, with an EV/FCF ratio of 24.98.
| EV / Earnings | -28.35 |
| EV / Sales | 2.76 |
| EV / EBITDA | 33.30 |
| EV / EBIT | 69.23 |
| EV / FCF | 24.98 |
Financial Position
The company has a current ratio of 5.09, with a Debt / Equity ratio of 1.96.
| Current Ratio | 5.09 |
| Quick Ratio | 1.90 |
| Debt / Equity | 1.96 |
| Debt / EBITDA | 0.35 |
| Debt / FCF | 0.27 |
| Interest Coverage | 13.57 |
Financial Efficiency
Return on equity (ROE) is -6.25% and return on invested capital (ROIC) is 1.53%.
| Return on Equity (ROE) | -6.25% |
| Return on Assets (ROA) | 1.28% |
| Return on Capital (ROIC) | 1.53% |
| Revenue Per Employee | 1.60M |
| Profits Per Employee | -155,696 |
| Employee Count | 1,075 |
| Asset Turnover | 0.51 |
| Inventory Turnover | 1.79 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -40.04% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -40.04% |
| 50-Day Moving Average | 153.37 |
| 200-Day Moving Average | 181.14 |
| Relative Strength Index (RSI) | 50.27 |
| Average Volume (20 Days) | 57,165 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, JMI Syringes & Medical Devices had revenue of BDT 1.72 billion and -167.37 million in losses. Loss per share was -5.57.
| Revenue | 1.72B |
| Gross Profit | 216.42M |
| Operating Income | 68.55M |
| Pretax Income | 62.76M |
| Net Income | -167.37M |
| EBITDA | 140.46M |
| EBIT | 68.55M |
| Loss Per Share | -5.57 |
Balance Sheet
The company has 29.99 million in cash and 50.49 million in debt, giving a net cash position of -20.50 million or -0.68 per share.
| Cash & Cash Equivalents | 29.99M |
| Total Debt | 50.49M |
| Net Cash | -20.50M |
| Net Cash Per Share | -0.68 |
| Equity (Book Value) | 2.58B |
| Book Value Per Share | 85.87 |
| Working Capital | 1.28B |
Cash Flow
In the last 12 months, operating cash flow was 200.09 million and capital expenditures -10.14 million, giving a free cash flow of 189.95 million.
| Operating Cash Flow | 200.09M |
| Capital Expenditures | -10.14M |
| Free Cash Flow | 189.95M |
| FCF Per Share | 6.32 |
Margins
Gross margin is 12.59%, with operating and profit margins of 3.99% and -9.74%.
| Gross Margin | 12.59% |
| Operating Margin | 3.99% |
| Pretax Margin | 3.65% |
| Profit Margin | -9.74% |
| EBITDA Margin | 8.17% |
| EBIT Margin | 3.99% |
| FCF Margin | 11.05% |
Dividends & Yields
This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 0.64%.
| Dividend Per Share | 1.00 |
| Dividend Yield | 0.64% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | 0.64% |
| Earnings Yield | -3.54% |
| FCF Yield | 4.02% |
Stock Splits
The last stock split was on November 15, 2022. It was a forward split with a ratio of 1.36.
| Last Split Date | Nov 15, 2022 |
| Split Type | Forward |
| Split Ratio | 1.36 |